Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if digoxin is safe and efficacious in treating
patients with non-alcoholic steatohepatitis (NASH) within the approved target range of 0.7 to
1 ng/ml.
Phase:
Phase 2
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School